Table 4.

Multivariate analysis of inflammatory and clinical characteristics in relation to 5-years LRRFS, DFS in ER+ HER2- early breast cancers not treated with chemotherapy (n=999).

Variables	LRRFS			Variables	LRRFS			DFS
	HR	95%CI	p		HR	95%CI	p	HR	95%CI	p
PLR				LMR
Low	0.42	0.22-0.81	0.009	Low	2.20	1.11-4.37	0.02	2.10	1.17-3.74	0.01
High	Ref.			High	Ref.			Ref.
Age	1.03	1.01-1.06	0.01	Age	1.03	1.00-1.06	0.03	1.04	1.01-1.06	0.002
pT				pT
pT1	1.16	0.38-3.57	0.80	pT1	1.14	0.38-3.48	0.81	0.82	0.37-1.79	0.61
pT2	Ref.			pT2	Ref.			Ref.
pN				pN
pN0	0.76	0.33-1.75	0.52	pN0	0.77	0.34-1.77	0.54	0.62	0.33-1.18	0.14
pN1	Ref.			pN1	Ref.			Ref.
Ki67				Ki67
≤14%	0.49	0.23-1.05	0.07	≤14%	0.58	0.27-1.23	0.16	0.48	0.26-0.88	0.01
>14%	Ref.			>14%	Ref.			Ref.
Grade				Grade
G1/2	1.13	0.36-3.55	0.83	G1/2	1.02	0.32-3.21	0.98	0.90	0.39-2.07	0.80
G3	Ref.			G3	Ref.			Ref.
Histological type				Histological type
Lobular	0.60	0.23-1.58	0.30	Lobular	0.65	0.25-1.71	0.38	0.61	0.27-1.38	0.24
Others	1.10	0.33-3.72	0.87	Others	1.14	0.34-3.83	0.83	0.78	0.24-2.56	0.68
Ductal	Ref.			Ductal	Ref.			Ref.